| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |